Arcellx Inc

ACLX

Company Profile

  • Business description

    Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

  • Contact

    800 Bridge Parkway
    Suite A
    RedwoodCA94065
    USA

    T: +1 240 327-0603

    https://www.arcellx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    163

Stocks News & Analysis

stocks

Undervalued ASX income play

Major development projects remain on schedule.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks

Going into earnings, Is Meta stock a buy, a sell, or fairly valued?

With a focus on leveraging its AI investments, here’s what we think of Meta stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,941.5015.300.17%
CAC 407,744.4153.81-0.69%
DAX 4024,041.90265.90-1.09%
Dow JONES (US)44,399.8576.780.17%
FTSE 1009,023.8110.820.12%
HKSE25,130.03135.890.54%
NASDAQ20,866.08108.10-0.52%
Nikkei 22539,774.9244.19-0.11%
NZX 50 Index12,833.74127.77-0.99%
S&P 5006,299.276.33-0.10%
S&P/ASX 2008,677.209.000.10%
SSE Composite Index3,581.8622.070.62%

Market Movers